Follow
Yvonne Martin
Yvonne Martin
Senior Volwiler Research Felllow, Abbott Laboratories (Retired) Volunteer, Neglected Diseases
Verified email at abbvie.com
Title
Cited by
Cited by
Year
QSAR modeling: where have you been? Where are you going to?
A Cherkasov, EN Muratov, D Fourches, A Varnek, II Baskin, M Cronin, ...
Journal of medicinal chemistry 57 (12), 4977-5010, 2014
18512014
A general and fast scoring function for protein− ligand interactions: a simplified potential approach
I Muegge, YC Martin
Journal of medicinal chemistry 42 (5), 791-804, 1999
13511999
Do structurally similar molecules have similar biological activity?
YC Martin, JL Kofron, LM Traphagen
Journal of medicinal chemistry 45 (19), 4350-4358, 2002
10542002
Use of structure− activity data to compare structure-based clustering methods and descriptors for use in compound selection
RD Brown, YC Martin
Journal of Chemical Information and Computer Sciences 36 (3), 572-584, 1996
8091996
A bioavailability score
YC Martin
Journal of medicinal chemistry 48 (9), 3164-3170, 2005
8052005
Quantitative drug design: a critical introduction
YC Martin
CRC Press, 2010
7972010
Utilization of operational schemes for analog synthesis in drug design
JG Topliss
Journal of medicinal chemistry 15 (10), 1006-1011, 1972
6261972
A fast new approach to pharmacophore mapping and its application to dopaminergic and benzodiazepine agonists
YC Martin, MG Bures, EA Danaher, J DeLazzer, I Lico, PA Pavlik
Journal of computer-aided molecular design 7, 83-102, 1993
5431993
The information content of 2D and 3D structural descriptors relevant to ligand-receptor binding
RD Brown, YC Martin
Journal of Chemical Information and Computer Sciences 37 (1), 1-9, 1997
4801997
3D database searching in drug design
YC Martin
Journal of Medicinal Chemistry 35 (12), 2145-2154, 1992
4311992
Novel 3-pyridyl ethers with subnanomolar affinity for central neuronal nicotinic acetylcholine receptors
MA Abreo, NH Lin, DS Garvey, DE Gunn, AM Hettinger, JT Wasicak, ...
Journal of medicinal chemistry 39 (4), 817-825, 1996
3041996
A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistry
YC Martin
Journal of medicinal chemistry 24 (3), 229-237, 1981
2981981
ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional …
JH Van Drie, D Weininger, YC Martin
Journal of Computer-Aided Molecular Design 3, 225-251, 1989
2731989
3D QSAR in drug design.
G Folkers, H Kubinyi, YC Martin
Kluwer Academic, 2002
2612002
Let’s not forget tautomers
YC Martin
Journal of computer-aided molecular design 23, 693-704, 2009
2552009
Evaluation of PMF scoring in docking weak ligands to the FK506 binding protein
I Muegge, YC Martin, PJ Hajduk, SW Fesik
Journal of medicinal chemistry 42 (14), 2498-2503, 1999
1961999
Quantitative structure-activity relationships of drugs
J Topliss
Elsevier, 2012
1952012
Glossary of terms used in computational drug design (IUPAC Recommendations 1997)
H Van de Waterbeemd, RE Carter, G Grassy, H Kubinyi, YC Martin, ...
Pure and applied chemistry 69 (5), 1137-1152, 1997
1681997
Application of belief theory to similarity data fusion for use in analog searching and lead hopping
SW Muchmore, DA Debe, JT Metz, SP Brown, YC Martin, PJ Hajduk
Journal of chemical information and modeling 48 (5), 941-948, 2008
1662008
Designing combinatorial library mixtures using a genetic algorithm
RD Brown, YC Martin
Journal of medicinal chemistry 40 (15), 2304-2313, 1997
1631997
The system can't perform the operation now. Try again later.
Articles 1–20